tumor lysate vaccine with Iscomatrix
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for tumor lysate vaccine with Iscomatrix, covering 2022-01-26 to 2022-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Adjuvant Tumor Lysate Vaccine and Iscomatrix With or Without Metronomic Oral Cyclophosphamide and Celecoxib in Patients With Malignancies Involving Lungs, Esophagus, Pleura, or Mediastinum [Phase 1, Phase 2]